Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA's Merial receives EMA approval for Broadline


Thursday, 12 Dec 2013 01:00am EST 

Sanofi SA:Says its animal health division Merial announced the approval by the European Medicines Agency (EMA) of Broadline, a product used against external and internal parasites in cats and kittens.Broadline is a topical product approved for the treatment and prevention of flea and tick infestations, prevention of heartworm disease, and the treatment of roundworm, hookworm, and tapeworm infestations in cats and kittens seven weeks of age and older. 

Company Quote

83.43
1.95 +2.39%
22 Oct 2014